login
Current Deals

company details

API HOLDINGS LIMITED

  • www.apiholdings.in
  • Sector: Retail
  • CHRYSEUM SCORE: 1.00/10.00
    ×

    API HOLDINGS LIMITED

    • Sector: Retail
    • CHRYSEUM SCORE: 1.00/10.00

    Description: API Holdings is a healthcare platform which operates an integrated, end-to-end business solving the healthcare needs of consumers through technology and fulfilment capabilities.

    Evaluation is basis the latest financial year disclosures filed by the company

    Valuation

    Max Score: 3.50

    P/E of Company

    -5.69

    AVG P/E of Key Peer/s

    -8.27

    Valuation Score

    0.00

    The Valuation Score depicts if the company is available at a discount when compared to its listed/unlisted peers. Higher the discount, more is the score given to the company.

    Growth

    Max Score: 3.50

    Sales Growth

    0.83%

    PAT Growth

    NA

    ROE

    -52.35%

    Growth Score

    0.00

    The Growth Score accounts for the growth in Sales and PAT on a 3 year CAGR basis and the Company’s ROE as per the latest financial year results released by the company.

    Leverage

    Max Score: 1.50

    Debt / Equity

    0.68

    AVG Industry Debt / Equity

    0.63

    Leverage Score

    0.50

    Lower the Debt/Equity, higher the score.

    Management Quality

    Max Score: 1.50

    Board Structure & Composition

    0.00

    Related Party Transactions

    1.00

    Timely Disclosure

    0.00

    Management Score

    0.50

    This score represents a consolidated view of the Company’s Management Quality, which includes Board Structure, Related Party Transactions and Timely disclosures. Each parameter is scored out of 1.

₹5.55 -0.05 (-0.89%)

As on 07 Nov, 2025
L 6.00 52 Week Range H 10.00
Company Description : API Holdings is a healthcare platform which operates an integrated, end-to-end business solving the healthcare needs of consumers through technology and fulfilment capabilities.
Company Overview
  • Name of Company API HOLDINGS LIMITED
  • Sector Retail
  • ISIN INE0DJ201029
  • Scrip Code PHARMEASY
  • CIN U60100MH2019PLC323444
  • Pan No AASCA1201E
  • Face Value 1
  • Price ₹ 5.55
  • No. of Shares outstanding 1,534.41 Cr.
  • Market Cap ₹ 8,515.98 Cr
Financials
  • Revenue from operations ₹ 5,872.16 Cr.
  • EBITDA ₹ -553.44 Cr.
  • EBITDA Margin % -9.42%
  • Profit After Tax ₹ -1,572.39 Cr.
  • PAT Margin % -26.29%
  • EPS -1.02
  • Stock P/E -5.44
  • Book Value Per Share 1.96
  • P/B 2.83
  • Debt/Equity 0.68
Other Key Statistics
  • 52 week High/Low 10.00/6.00
  • Dividend Per Share 0.00
  • Dividend Yield 0.00%
  • Sales Growth - 3 years 0.83%
  • EBITDA Growth - 3 years NA
  • PAT Growth - 3 years NA
  • EPS Growth - 3 years NA
  • ROE -52.35%
  • ROCE -13.91%
  • Cash Equivalents 739.76
All figures below are in INR Crores unless otherwise stated

Profit Loss

FY25 FY24 FY23 FY22 FY21
Revenue from operations 5,872.16 5,664.29 6,643.94 5,728.82 2,335.27
Y-o-Y Revenue Growth 3.67% -14.75% 15.97% 145.32% 249.83%
Other Income 107.87 94.66 55.83 52.18 25.39
Total Income 5,980.03 5,758.94 6,699.77 5,781.00 2,360.66
Total Expenses (Excludes Interest and Depreciation) 6,533.47 6,310.93 8,065.03 8,074.55 2,904.60
Operating Profit (After deducting Depreciation) -661.31 -646.65 -1,421.09 -2,504.51 -602.23
OPM % -11.26 -11.42 -21.39 -43.72 -25.79
EBITDA -553.44 -551.99 -1,365.26 -2,293.55 -543.94
Depreciation 168.98 215.95 243.44 158.78 32.90
EBIT -722.42 -767.94 -1,608.70 -2,452.33 -576.84
Interest 506.11 727.92 665.54 258.26 43.43
EBT before Exceptional Items -1,228.53 -1,495.86 -2,274.24 -2,710.59 -620.27
Prior period/Exceptional /Extra Ordinary Items 288.36 1,026.00 2,921.98 1,260.19 0.00
Profit before tax/EBT -1,516.89 -2,521.86 -5,196.22 -3,970.78 -620.27
Tax 55.50 11.54 15.21 21.72 21.07
Net Profit -1,572.39 -2,533.40 -5,211.44 -3,992.50 -641.34
Profit (loss) of minority interest 0.00 -16.40 -7.03 0.00 0.00
Total profit (loss) for period -1,572.39 -2,517.00 -5,204.41 -3,992.50 -641.34
EPS in Rs -1.02 -1.65 -3.40 -2.60 -206.77
EPS Change % -37.93% -51.39% 30.53% -98.74% 60.10%
EBITDA Change % 0.26% -59.57% -40.47% 321.65% 71.97%
Profit growth -37.93% -51.39% 30.53% 522.52% 91.28%
ROCE -13.91% -15.71% -17.84% -32.11% -14.76%
ROE -52.35% -114.40% -85.21% -59.61% -18.65%
Debt / Equity Ratio 0.68 1.85 0.57 0.39 0.13
Sales growth 3Years 0.83%
Sales growth 5Years 54.48%
Dividend per share 0.00

Balance Sheet

FY25 FY24 FY23 FY22 FY21
Share Capital 651.67 624.04 614.25 614.20 25.62
Reserves 2,352.21 1,590.40 5,143.84 6,083.08 3,413.76
Total shareholders' funds 3,003.88 2,214.44 6,115.69 6,697.28 3,439.38
Borrowings 2,033.67 4,098.36 3,511.07 2,585.41 433.82
Other Liabilities 922.12 937.11 961.21 1,066.96 464.81
Total Liabilities 3,704.30 5,801.35 5,226.96 4,375.84 1,303.40
Fixed Assets 793.24 871.85 513.28 560.86 61.37
Capital WIP 14.16 2.76 5.86 6.95 0.25
Investments 155.12 154.22 139.99 141.42 0.92
Other Assets 441.25 428.85 1,184.20 1,463.94 386.33
Total Assets 6,976.58 8,389.66 11,342.65 11,398.32 4,884.58
Cash Equivalents 739.76 1,610.49 286.95 329.20 323.18
Total Current liability 1,781.21 3,502.48 2,327.02 3,761.60 976.21
Total Assets -Total Current liabilty 5,195.37 4,887.18 9,015.63 7,636.72 3,908.37

Cash Flow

FY25 FY24 FY23 FY22 FY21
Net Cash from / (used in) Operating Activity -223.53 -61.14 -730.11 -2,589.36 -820.91
Net Cash from / (used in) Investing Activity 774.96 -1,260.95 -100.07 -5,789.20 3.67
Net Cash from / (used in) Financing Activity -759.91 1,456.83 855.34 8,305.36 1,022.62
Net Inc/Dec In Cash And Cash Equivalents -208.48 134.75 25.17 -73.20 205.38

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 0.00 0.00%
Non Promoters 1,534.41 100.00%

News

© 2022 Chryseum Advisors LLP. All rights reserved. LLPIN – AAD-0626

+91 98925 31672 | info@chryseum.in

For latest updates

Linkedin-in